Related Experiment Video
Updated: Jun 26, 2025
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
38.9K
Wearable dual-drug controlled release patch for psoriasis treatment
Jiaxin Zhao1, Shengen Gong1, Yueming Mu2
1College of Chemistry, Jilin University, Changchun 130012, China.
Journal of Colloid and Interface Science
|May 15, 2024
Summary
This study introduces a smart wearable patch for precise dual-drug delivery, combining dexamethasone and tannic acid for synergistic psoriasis treatment. The innovative patch offers an efficient and on-demand therapeutic option.
Area of Science:
- Biomedical Engineering
- Materials Science
- Pharmacology
Background:
- Wearable drug delivery systems (DDS) are crucial for precision medicine, enabling controlled drug dosage, timing, and location.
- Current wearable DDS aim for simplicity, efficiency, and intelligence in drug administration.
- Monotherapy often faces limitations in treating complex conditions like psoriasis.
Purpose of the Study:
- To develop and evaluate a novel wearable dual-drug synergistic release patch.
- To investigate the simultaneous delivery of dexamethasone and tannic acid for enhanced therapeutic effects.
- To demonstrate the efficacy of on-demand drug release for psoriasis treatment.
Main Methods:
- A wearable patch was designed using a magnesium battery and a hydrogel incorporating viologen-based hyperbranched polyamidoamine.
- The hydrogel served as both the cathode material and a reservoir for dexamethasone and tannic acid.
- The patch's performance was assessed in a mouse model of praziquimod-induced psoriasis.
Main Results:
- The wearable patch successfully achieved simultaneous, on-demand release of dexamethasone and tannic acid.
- Therapeutic efficacy was demonstrated at a low voltage in a mouse model.
- Inflammatory skin lesions in the psoriasis model resolved within 5 days of treatment.
Conclusions:
- The proposed wearable dual-drug patch offers a straightforward and effective approach for synergistic therapy.
- This system overcomes limitations of monotherapy by providing on-demand, combined drug release.
- The technology presents a promising new treatment strategy for inflammatory skin conditions.
Related Concept Videos
01:22Drug Delivery: Miscellaneous Routes
338
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
338
01:28Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
167
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
167
01:01Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
01:29Drug Delivery: Parenteral Route
504
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
504
01:15Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K